Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate ...

Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Last year, legislation calling for a Prescription Drug Affordability Board cleared the General Assembly but was vetoed by Gov ...

Legislators plan a confrontation with Gov. Glenn Youngkin over two of his highest-profile vetoes last year: bills for a state ...

Gov. Maura Healey signed two major healthcare reform bills Wednesday — one that looks to increase hospital oversight in the ...